Navigation Links
A new role for milk: Delivering polyphenols with anti-cancer activity
Date:12/19/2013

r cell proliferation after EGCG was added to different milk products, including skim milk, milk whey, and milk serum. While some differences were noted in cell proliferation at lower concentrations between EGCG in control medium and EGCG diluted in the milk components, at higher EGCG concentrations (0.8 mg/mL and above), EGCG reduced cancer cell growth by 80% or more, whether diluted in milk or not.

"In order to exert their biological health benefits in vivo, polyphenols must be available and still active, even when present in a food matrix," comments Dr. Haratifar. "This study showed that the binding of EGCG to the casein micelles did not affect the bioefficacy of EGCG and cell uptake at concentrations higher than 0.03 mg of EGCG/mL of skim milk."


'/>"/>

Contact: Eileen Leahy
jdsmedia@elsevier.com
732-238-3628
Elsevier Health Sciences
Source:Eurekalert

Page: 1 2

Related biology news :

1. Nanotherapy: Treating deadly brain tumors by delivering big radiation with tiny tools
2. Small packages delivering huge results
3. Researchers engineer a hybrid 5 times more effective in delivering genetic material into cells
4. Sticking power of plant polyphenols used in new coatings
5. University of Hawaii Cancer Center researchers create new anti-cancer drug
6. Molecular movies may accelerate anti-cancer drug discovery
7. Biologists engineer algae to make complex anti-cancer designer drug
8. New study highlights strong anti-cancer properties of soybeans
9. New Research: Modified Citrus Pectin - A Potent Anti-Cancer Therapy
10. USC scientists ID protein that regulates cellular trafficking, potential for anti-cancer therapy
11. Trial combining anti-cancer drug and radiotherapy may lead to treatment for brain tumor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Rio de Janeiro, Brazil- In the brains of ... mechanism that allows an electric or chemical signal ... another. Chemical synapses, which are the most abundant ... inhibitory. Synapse formation is crucial for learning, memory, ... and inhibitory synapses critical for brain function. ...
(Date:7/10/2014)... 1, 2014 Smart technology emphasis grows ... and improved security: NXT-ID, Inc. (OTCBB: NXTD), eBay Inc. (NASDAQ: ... ), Apple Inc. (NASDAQ: AAPL ), Visa Inc. ... NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company focused ... the second series of 30 second spots on CNBC for ...
(Date:7/10/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/h7h8lq/gesture ... "Global Gesture Recognition & Touch-Less Sensing (2D, 3D, ... report to their offering ... & Touch-Less Sensing Market to Grow Exponentially. Touch-less ... but the companies were unable to leverage this ...
Breaking Biology News(10 mins):Blame it on the astrocytes 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5Global Gesture Recognition & Touch-Less Sensing (2D, 3D, Ultrasonic, IR, Capacitive) Market - Forecasts to 2020 2
... the building of high speed rail lines in China will ... Professor Rongfang (Rachel) Liu takes the stage at the annual ... the world,s largest gathering in transportation, if not all of ... Liu, an expert in high speed rail lines ...
... mounting concerns over childhood obesity and its associated health ... advertising aimed at children be more effective than the ... a University of Illinois economist, advertising bans do work, ... market would be the most effective policy tool for ...
... beetle dance provides crucial orientation cues: Beetles climb on top of ... The dung beetle dance, performed as the beetle moves away from ... to maintain the desired straight-line departure from the pile, according to ... journal PLoS ONE . The purpose of this ...
Cached Biology News:NJIT high speed rail expert to address DC conference next week 2NJIT high speed rail expert to address DC conference next week 3Study: Quebec ban on fast-food ads reduced consumption of junk food 2Study: Quebec ban on fast-food ads reduced consumption of junk food 3
(Date:7/11/2014)... BCC Research ( http://www.bccresearch.com ) reveals ... REACTION (PCR) TECHNOLOGY: GLOBAL MARKETS , the global market ... $140 billion in 2013. This is estimated to grow ... annual growth rate (CAGR) of 28.6%. , New digital ... exciting possibilities within the broader PCR field. The opportunities ...
(Date:7/11/2014)... 11, 2014 /CNW/ - Sunovion Pharmaceuticals Canada Inc. (Sunovion) ... (eslicarbazepine acetate) for use as a once-daily adjunctive therapy ... epilepsy who are not satisfactorily controlled with conventional therapy. ... patients under 18 years of age. ... and according to Epilepsy Canada, it affects 0.6% of ...
(Date:7/11/2014)... July 11, 2014 Cayenne Medical, ... specializing in the soft tissue reconstruction segment, announced ... System for surgeries involving the shoulder and extremities. ... a novel, inserter-controlled deployment method. The unique delivery ... deployment, anchor pull-out, or anchor displacement (also commonly ...
(Date:7/10/2014)... Product and process impurities in biopharmaceuticals ... are often “lost in the noise,” making their ... Dr. Rowel Tobias, Senior Scientist, Protein Chemistry at ... Quality at Nanotherapeutics, Inc., to lear about a ... and quantitation while achieving the required specificity and ...
Breaking Biology Technology:Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 3Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2
... SAN FRANCISCO and WASHINGTON , ... Inc., a clinical-stage cancer biotherapeutics company, today reported positive ... the intravenous (IV) administration of JX-594 to patients with ... delivery to solid tumors, cancer-targeted replication and gene expression, ...
... NEW YORK , May 20 /PRNewswire-Asia-FirstCall/ -- ... "Company"), an international,biopharmaceutical company with operations in the U.S. ... of Convertible Redeemable Series C Preferred Stock,(Series C Preferred) ... the conversion of the Series C Preferred, the Company ...
... by Ki H. Chon, PhD, head of the Department ... partnership with Snehraj Merchant of The ScottCare Corporation, makes ... detect incidents of atrial fibrillation (AF), the most common ... methods. The algorithm, utilized in the new ScottCare CardioView ...
Cached Biology Technology:Jennerex Reports Positive Phase 1 Results for JX-594 Administered Intravenously 2Jennerex Reports Positive Phase 1 Results for JX-594 Administered Intravenously 3Jennerex Reports Positive Phase 1 Results for JX-594 Administered Intravenously 4NeoStem Announces Conversion of Convertible Preferred Stock by Principal Shareholder 2NeoStem Announces Conversion of Convertible Preferred Stock by Principal Shareholder 3NeoStem Announces Conversion of Convertible Preferred Stock by Principal Shareholder 4Detection of potentially deadly atrial fibrillation dramatically improved by new algorithm 2Detection of potentially deadly atrial fibrillation dramatically improved by new algorithm 3
... Chicken polyclonal to Opsin 1 ( Abpromise ... Antigen: Synthetic peptide: YEDSTHASIFTYT, corresponding to amino ... and synthetic peptide corresponding to amino acids 18/30 ... and used as immunogen. Entrez ...
Goat polyclonal to p27 KIP 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-KRPATDDS STQNK, corresponding to Internal sequence amino acids 153-165 of Human p27 KIP 1 ...
Request Info...
Myt 1 (N-17)...
Biology Products: